The Ministry of Health announced the suspension of the practice licenses of two doctors, after monitoring a promotional clip in which they used their professional status and their kinship to gain public trust and promote the injection of an exosome product as a safe procedure.
The Ministry explained that the clip presented one of the two doctors undergoing injections at the hands of his brother as evidence of the quality and safety of the product, using the community’s trust in the health practitioner and the family relationship as an alternative to scientific evidence and regulatory accreditation.
She stressed that the safety and quality of health products are not proven by individual experiences or personal trust, but rather by scientific studies, quality and manufacturing requirements, product classification and approval for specific use by the competent authorities.
It indicated that the product used is intended, according to the instructions written on its packaging, for external use only, and that using it by injection violates its specific method of use, and that allowing it to be circulated externally does not permit its injection or the promotion of its safety in this way.
The violations included exploiting professional status in marketing, publishing unproven claims about quality and safety, using the product contrary to its instructions, and publishing commercial medical content that would mislead beneficiaries.
The Ministry indicated that these practices conflict with the provisions of the Law on the Practice of Health Professions, which prohibits the practice of treatment methods that are not scientifically recognized, and obliges the health practitioner to stay away from sensationalistic commercial propaganda methods that are not based on scientific foundations, and to adhere to accuracy and professional responsibility in what he publishes.
She stressed that the suspension decisions come to preserve the safety of the beneficiaries until the completion of the regulatory procedures, stressing that the professional capacity is a responsibility that may not be used to influence the public’s decisions or market products and procedures without reliable scientific and regulatory evidence, and called on the Ministry to report violating health practices through the “937” call center.
The Ministry of Health announced the suspension of the licenses of two doctors after a promotional video was detected in which they exploited their professional status and their familial relationship to gain public trust and promote an exosome product as a safe procedure.
The ministry clarified that the video presented one of the doctors receiving an injection from his brother as evidence of the product’s quality and safety, using the community’s trust in health practitioners and their family relationship as a substitute for scientific evidence and regulatory approval.
It emphasized that the safety and quality of health products are not established through individual experiences or personal trust, but through scientific studies, quality and manufacturing requirements, and the classification and approval of the product for specific use by the relevant authorities.
It indicated that the product used is designated according to the instructions written on its packaging for external use only, and that using it via injection contradicts its specified method of use, and allowing it to be used externally does not permit its injection or the promotion of its safety in this manner.
The violations included exploiting professional status for marketing, spreading unproven claims regarding quality and safety, using the product contrary to its instructions, and publishing commercial medical content that could mislead beneficiaries.
The ministry pointed out that these practices contradict the provisions of the Health Professions Practice System, which prohibits the use of scientifically unrecognized treatment methods, requires health practitioners to avoid sensational commercial advertising not based on scientific foundations, and mandates adherence to accuracy and professional responsibility in what they publish.
It confirmed that the suspension decisions are made to protect the safety of beneficiaries until the regulatory procedures are completed, stressing that professional status is a responsibility that should not be used to influence public decisions or market products and procedures without reliable scientific and regulatory evidence, and the ministry urged reporting any violations of health practices through the contact center “937”.
